<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 29-Jul-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (29-Jul-2025)</h1>
<h2>Top News Highlights</h2>
<ul>
<li>Major US-EU trade deal reached, but France and Germany express dissatisfaction; markets await further trade policy clarity.</li>
<li>S&amp;P 500 and Nasdaq hit new record highs as investors anticipate Big Tech earnings and upcoming Fed decision.</li>
<li>Pentagon implements ban on staff participation in some think tank events over &quot;America last&quot; concerns.</li>
<li>FDA lifts voluntary hold on Sarepta's Elevidys gene therapy for Duchenne muscular dystrophy.</li>
<li>Sony sues Tencent over alleged copyright infringement in gaming IP.</li>
<li>Extreme heat in the US Southeast; Tampa hits 100°F for the first time.</li>
<li>Ongoing instability in the Middle East, with significant global humanitarian and geopolitical focus.</li>
<li>Reports of rising violent incidents in US cities (NYC, Reno, Michigan) with minor immediate macro impact but heightened social risk sentiment.</li>
<li>Major shake-up scheduled at Warner Bros. Discovery, with a corporate breakup into separate Warner Bros. and Discovery companies.</li>
<li>NASA and SpaceX prepare for Crew-11 astronaut launch.</li>
</ul>
<hr />
<h2>Macro &amp; Policy</h2>
<h3>Economic Growth, Inflation, and Fed Outlook</h3>
<ul>
<li><strong>Growth</strong>: Market-implied expectations point toward tepid US GDP growth (~1.5-2.5%) in 2025, with a sizable risk of sub-1.5% growth (recession risk persists into 2027). US unemployment is expected to drift upward, with the next print likely in the low-4% range.</li>
<li><strong>Inflation</strong>: Core inflation is expected to stay above the Fed's target (most likely in the 2.5-4% corridor), complicating aggressive rate cut scenarios.</li>
<li><strong>Fed Policy</strong>: Multiple FOMC dissents anticipated at the next meeting. Consensus expects 1-2 cuts this year (with a strong chance of at least one). Year-end policy rate most expected above 3.5%. Odds of an emergency Fed meeting remain limited.</li>
<li><strong>National Debt &amp; Fiscal</strong>: US debt expected to cross $38T by year-end but with little support for meaningful deficit reduction or ambitious spending cuts this year. Fiscal policy will remain loose, with further increases in government outlays likely, supporting short-term growth but raising medium-term rate and credit risk. Anticipate pressure on longer-dated Treasuries, continued debate over sustainability, and potential further curve steepening.</li>
</ul>
<p><strong>Investment Implication</strong>: Cautious bias toward duration risk in fixed income; overweight quality/defensive equities over cyclicals or leveraged names; maintain inflation hedges. Fed likely supporting soft landing but not aggressively easing.</p>
<hr />
<h3>Trade, Geopolitics, and Currency</h3>
<ul>
<li><strong>US Trade Policy</strong>: New tariffs appear imminent and broad-based, with high likelihood of targeting China, South Korea, Japan, Taiwan, Mexico, the EU, and Canada. Exceptionally high odds of copper tariffs; revenues from tariffs to surge.</li>
<li><strong>USD &amp; De-dollarization</strong>: USD index at risk of making yearly lows, reflecting trade tensions and fiscal indiscipline. This creates headwinds for imported inflation and potential tailwinds for non-USD assets and commodities.</li>
<li><strong>G7/EU Instability</strong>: Japanese leadership seen as most vulnerable among G7 heads, increasing uncertainty in JPY and Japanese equity exposure. Moderate odds of an EU member exit (Hungary/Italy) but higher probability of further expansion (new member accession).</li>
<li><strong>China</strong>: Unlikely to surpass the US in GDP by 2030, but trade friction will remain intense.</li>
</ul>
<p><strong>Investment Implication</strong>: Underweight exporters directly exposed to targeted US tariffs; overweight commodity exposures that may benefit from supply disruptions (e.g., select metals, agricultural commodities). Flex positioning in FX, with cautious USD and opportunistic exposure to commodity currencies and EMs with resilient trade balances.</p>
<hr />
<h2>Sectors &amp; Themes</h2>
<h3>Technology &amp; AI</h3>
<ul>
<li><strong>Antitrust Overhang</strong>: US courts are likely to advance antitrust cases against Amazon, Apple, and Live Nation in the years ahead, creating persistent headline risk for these names and the broader FAANG cohort. Expect more regulatory scrutiny and possible structural remedies.</li>
<li><strong>Semiconductors</strong>: US domestic semiconductor production continues to surge—on target for mid-to-high single-digit growth rates—benefiting onshoring and CHIPS Act exposed companies.</li>
<li><strong>AI &amp; Regulation</strong>: Moderate possibility of government intervention or seizure in prominent AI projects ahead of 2030, plus growing litigation risk (notably for OpenAI).</li>
<li><strong>Labor &amp; Tech</strong>: High probability of further tech layoffs in 2025 as the sector digests post-pandemic overcapacity and margin pressure.</li>
</ul>
<p><strong>Investment Implication</strong>: Stay overweight US semiconductor manufacturers and AI infrastructure providers. Remain alert to antitrust/legal developments in large tech. Position for margin improvement among techs post-layoffs, but be guarded on mega-cap multiples given regulatory pressure.</p>
<hr />
<h3>Energy &amp; Climate</h3>
<ul>
<li><strong>Climate Goals</strong>: US and EU are unlikely to meet 2030 emission targets, while India is on track. Global energy mix will remain dominated by coal and oil, with slow renewable penetration, but solar installation in the US continues to ramp sharply.</li>
<li><strong>Commodities</strong>: Oil prices forecast to be volatile and biased lower by year-end, but risk of upside tail remains due to geopolitics. Natural gas expected to remain relatively elevated. Copper tariffs and supply disruptions merit close monitoring for price spikes.</li>
<li><strong>ESG</strong>: CO₂ concentrations likely to surpass 440 ppm. Climate and energy transition remain investment themes but require realism about pace and volatility.</li>
</ul>
<p><strong>Investment Implication</strong>: Flex commodities exposure with bias toward volatility strategies. Underweight European energy transition stories expecting rapid near-term transition. Maintain select exposure to Indian renewables and coal/oil for defensive play.</p>
<hr />
<h3>Healthcare &amp; Biotech</h3>
<ul>
<li><strong>Innovation</strong>: Near-term FDA approval for a Type 1 diabetes cure remains low-probability, but high level of market attention means any breakthrough will be highly consequential for exposed biotechs.</li>
<li><strong>Gene Therapy</strong>: Positive regulatory news for Sarepta (Elevidys), but with caution around adverse event headlines.</li>
<li><strong>Psychedelics</strong>: 50/50 prospect of first FDA-approved psychedelic therapy by 2027—a high-conviction watchlist for speculative biotech and pharma investors.</li>
</ul>
<p><strong>Investment Implication</strong>: Healthcare innovation remains a viable long-term growth space, but headline-driven volatility will persist. Focus on companies with multiple shots on goal and those less exposed to regulatory binary events.</p>
<hr />
<h3>Consumer, Discretionary &amp; Media</h3>
<ul>
<li><strong>Video Games</strong>: Prices for blockbuster titles are likely to continue rising, reflecting ongoing inflation and IP risk, as seen with Sony/Tencent litigation.</li>
<li><strong>Streaming</strong>: Netflix may announce further price increases; Disney/Warner Bros. Discovery restructuring may inject M&amp;A and headline volatility into the sector.</li>
<li><strong>Events</strong>: Consumer sensitivity to event/pricing remains visible with lack of traction for high-cost tickets (e.g., Fyre Festival 2).</li>
</ul>
<p><strong>Investment Implication</strong>: Lean into companies with strong pricing power, but be cautious with media and entertainment names exposed to regulatory flux (e.g., antitrust) or who lack unique IP.</p>
<hr />
<h3>Crypto, Payments &amp; Financials</h3>
<ul>
<li><strong>Crypto Mainstreaming</strong>: Corporate treasury Bitcoin purchases by S&amp;P 500 names expected to accelerate. Odds rising for crypto market structure legislation; tax clarity remains less certain.</li>
<li><strong>Performance</strong>: Bitcoin and Ethereum likely to remain well bid barring major reversals. Relative outperformance expected from Ripple this year among large-caps.</li>
<li><strong>Banking</strong>: JPMorgan continues to push back against fintech intermediaries—sector in flux regarding monetization/data rights. Potential for consolidation and higher tech sector costs.</li>
</ul>
<p><strong>Investment Implication</strong>: Barbell exposure to blue-chip crypto and crypto infrastructure, with close monitoring for fresh regulatory momentum. Stay agile with fintech names, focusing on those with defensible market power or alignment with major incumbents.</p>
<hr />
<h2>Key Individual Names/Events</h2>
<ul>
<li><strong>JPMorgan</strong>: Probable leadership change ahead; watch for operational or strategic shifts.</li>
<li><strong>Tesla</strong>: Robotaxi in California this year remains unlikely; scrutiny remains on regulatory/timetable slippage.</li>
<li><strong>OpenAI</strong>: High litigation/tort damage risk this cycle. AI sector more generally faces rising legal costs and regulatory pressure.</li>
<li><strong>Warner Bros. Discovery</strong>: Pending corporate breakup—possible catalysts for restructuring plays or asset rotation.</li>
<li><strong>Sony/Tencent</strong>: Litigation over gaming IP highlights intensifying competition and legal exposure in global gaming.</li>
</ul>
<hr />
<h2>Tactical Considerations</h2>
<ul>
<li>Favor: Defensive/quality equities, semis &amp; AI infra, Indian renewables, US health innovation, select crypto, event-driven restructuring stories</li>
<li>Caution: Direct exporters (esp. those facing new US tariffs), EU energy transition overhype, FAANGs/mega-caps facing regulatory/legal overhangs, levered cyclicals, structurally unprofitable tech</li>
<li>Watch: US fiscal/monetary policy inflections, China/US trade developments, regulatory news flow in AI, antitrust, and crypto</li>
</ul>
<hr />
<p><em>Prepared with a second-order, cross-asset lens. For allocation ideas, refer to sector and theme implications above.</em></p>

</main>
</body>
</html>
